ArticleACS omega2025
Enhanced Ear Cartilage Regeneration with Dual-Network LT-GelMA/F127DA Hydrogel Featuring Nanomicelle Integration.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tissue-engineered cartilage, supported by advancements in photo-cross-linkable hydrogels, offers a promising solution for the repair and regeneration of damaged cartilage in anatomically complex and mechanically demanding sites. Low-temperature soluble GelMA (LT-GelMA) remains in a liquid state at room temperature, allowing for easier handling; however, it has limitations in mechanical strength and structural stability. To address these limitations, we developed a novel dual-network hydrogel combining LT-GelMA with Pluronic F127-diacrylate (F127DA). The resulting hydrogel uniquely integrates the low-temperature solubility of LT-GelMA with the enhanced mechanical strength provided by photo-cross-linkable F127DA nanomicelles. Additionally, the hydrogel exhibits controlled swelling and biodegradation rates. In vitro studies revealed a significant increase in chondrocyte viability by day 7 in formulations with higher F127DA concentrations. In vivo, the hydrogel demonstrated superior neo-cartilage formation in a subcutaneous nude mouse model, as indicated by increased deposition of cartilage-specific extracellular matrix components at 4 and 8 weeks. In summary, we developed a hydrogel with fluidity at room temperature and enhanced mechanical performance. These results indicate that the LT-GelMA/F127DA hydrogel effectively addresses the current gaps in cartilage tissue engineering. The hydrogel's superior performance, especially in promoting cartilage regeneration, positions it as a promising alternative for reconstructive surgery, representing a significant improvement over existing cartilage repair strategies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.